![](/img/cover-not-exists.png)
P363 Discontinuation of 5-aminosalicylates after starting biologic therapy in patients with ulcerative colitis is not associated with adverse outcomes
Limketkai, B, Ungaro, R, Jess, T, Allin, K, Agrawal, M, Ullman, T, Colombel, J -FVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.490
Date:
January, 2018
File:
PDF, 569 KB
english, 2018